Target
Beta-lactamase
Ligand
BDBM361143
Substrate
n/a
IC50
0.068±n/a nM
Citation
 Bennett, FJiang, JPasternak, ADong, SGu, XScott, JDTang, HZhao, ZHuang, YYang, DYoung, KXiao, LZhang, ZFu, J Metallo-beta-lactamase inhibitors US Patent  US10544130 Publication Date 1/28/2020 
Target
Name:
Beta-lactamase
Synonyms:
n/a
Type:
Protein
Mol. Mass.:
29508.45
Organism:
n/a
Description:
Q2QC95
Residue:
266
Sequence:
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG
 
Inhibitor
Name:
BDBM361143
Synonyms:
(R)—N1-(3-amino-2-hydroxypropyl)-4-(2-(aminomethyl)benzo[d]thiazol-4-yl)-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide | US10221163, Example 300 | US10544130, Example 300
Type:
Small organic molecule
Emp. Form.:
C18H21N9O5S3
Mol. Mass.:
539.612
SMILES:
NC[C@@H](O)CNS(=O)(=O)c1ccc(-c2cccc3sc(CN)nc23)c(-c2nn[nH]n2)c1S(N)(=O)=O |r|
Structure:
Search PDB for entries with ligand similarity: